Musaffa Logo
Torrent Pharmaceuticals Ltd TORNTPHARM.NS

Last Updated: Jul 21, 12:00 AM·NSE

TORNTPHARM.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Torrent Pharmaceuticals Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd. Stock Analysis TORNTPHARM.NS

India Health Care Large Cap Report:
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. The company is headquartered in Ahmedabad, Gujarat and currently employs 16,107 full-time employees. The firm is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The firm is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.
Read More

Torrent Pharmaceuticals Ltd (TORNTPHARM.NS) Chart

Key Statistics of Torrent Pharmaceuticals Ltd (TORNTPHARM.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹4,948.00₹5,050.00

Today's Open

₹4,978.40

Volume

287.69K

P/E Ratio (TTM)

74.58

52 Week Range

₹3,421.30₹5,085.80

Market Cap

1.64T

Avg. Volume

811.39K

Dividend Yield

0.80%

Financial Metrics & Statements of Torrent Pharmaceuticals Ltd (TORNTPHARM.NS)

Super Investors Invested in Torrent Pharmaceuticals Ltd (TORNTPHARM.NS)

FAQ's for Torrent Pharmaceuticals Ltd (TORNTPHARM.NS)

  • As of July 2026, Torrent Pharmaceuticals Ltd TORNTPHARM.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Torrent Pharmaceuticals Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Torrent Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Torrent Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Torrent Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Torrent Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.